Join the team at Citeline for an exclusive preview of its long-running Pharma R&D Annual Review. Pharmaprojects’ annual review of trends in pharmaceutical R&D takes the temperature of the industry at the start of 2024 by assessing the pipeline by company, therapeutic area, disease, target, and emerging drug modalities and regional variations.
